Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Comprehensive Care Corp. (OTC: CHCR).

Full DD Report for CHCR

You must become a subscriber to view this report.


Recent News from (OTC: CHCR)

Advanzeon Solutions, Inc. Expands Management Team and Presence in California
TAMPA, FL --(Marketwired - April 30, 2018) - Advanzeon Solutions, Inc. (OTCBB: CHCR) ("Advanzeon" or the "Company") announced today that it has expanded its management team by electing Dr. Stephen Kreitzer, currently serving as the Company's Medical Director, to the Company's Board of Di...
Source: Marketwired
Date: April, 30 2018 10:00
Advanzeon Solutions, Inc. to File 10-K for 2013 and 2014
TAMPA, FL --(Marketwired - April 27, 2018) - Advanzeon Solutions, Inc. (OTCBB: CHCR) ("Advanzeon or the "Company") announced today that it anticipates filing its Annual Report on Form 10-K ("10-K") for the fiscal years ending 2013 and 2014 by May 9, 2018. Clark A. Marcus, the Company's...
Source: Marketwired
Date: April, 27 2018 11:15
Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Enters Into Agreement With Interstate Specialty Marketing, Inc.
TAMPA, FL --(Marketwired - April 05, 2018) - Advanzeon Solutions, Inc. (OTCBB: CHCR) ("Advanzeon") announced today that, through its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company"), it has entered into an Agreement with Interstat...
Source: Marketwired
Date: April, 05 2018 10:00
Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary, Pharmacy Value Management Solutions, Inc. Enters Into Agreement With T A Baxter, LLC
TAMPA, FL --(Marketwired - March 26, 2018) - Advanzeon Solutions, Inc. (OTCBB: CHCR) ("Advanzeon") announced today that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") has entered into an Agreement with T A Baxter, LLC ("Baxter"), a specialty pharmaceutica...
Source: Marketwired
Date: March, 26 2018 10:04
Advanzeon Solutions, Inc. and MYnd Analytics, Inc. Announce Expanded Collaboration Between their Wholly Owned Subsidiaries, Pharmacy Value Management Solutions, Inc. and Arcadian Telepsychiatry Services
TAMPA, Fla., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Advanzeon Solutions, Inc. (OTCBB:CHCR) ("Advanzeon") and MYnd Analytics, Inc. (NASDAQ:MYND) announced today that Advanzeon’s wholly owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS"), and MYnd’s wholly owned subs...
Source: GlobeNewswire
Date: February, 20 2018 07:30
Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Signs Agreement with The Independent Contractors Alliance Corp.
Advanzeon Solutions, Inc.’s (OTCBB:CHCR) ("Advanzeon") wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company") announced today that it has signed an Agreement with the Independent Contractors Alliance Corp. (“ICA”). The A...
Source: Business Wire
Date: February, 12 2018 10:00
Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Attaining Preferred Provider Status With Most Major Insurance Carriers For Its Sleep Apnea Services
Advanzeon Solutions, Inc.’s (OTCBB:CHCR) ("Advanzeon") wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company") announced today that it has received approval from most of the major insurance carriers to begin direct billing for patients...
Source: Business Wire
Date: January, 22 2018 15:37
Advanzeon Solutions, Inc.'s Wholly-Owned Subsidiary Pharmacy Value Management Solutions, Inc. Announces Medical Director and Members of Its Medical Advisory Board Voted Top Doctors by Peers
Advanzeon Solutions, Inc.’s (OTCBB:CHCR) ("Advanzeon") wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company") announced today that its Medical Director and many members of its Medical Advisory Board for its SleepMaster SolutionsȒ...
Source: Business Wire
Date: December, 04 2017 10:42
Advanzeon Solutions, Inc. Retains Philip C. Pulver as Communications Director and Chief Consultant for Contract Negotiations
Advanzeon Solutions, Inc. (OTCBB:CHCR) ("Advanzeon") and its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. ("PVMS") (collectively, the "Company") announced today that it has retained the services of Philip C. Pulver to serve as the Company’s Communications Directo...
Source: Business Wire
Date: October, 16 2017 10:00
Advanzeon Solutions, Inc. Expects to Post a Profit for Q4 of 2016
Advanzeon Solutions, Inc. (“Advanzeon” or the “Company”) (OTCBB:CHCR) today announced that it expects to show a slight profit for the quarter ended December 31, 2016. The expected profit includes revenue and non-operating revenue sources. Mark T. Heidt, the Compan...
Source: Business Wire
Date: January, 17 2017 11:21

 


About Comprehensive Care Corp. (OTC: CHCR)

Logo for Comprehensive Care Corp. (OTC: CHCR)

Comprehensive Behavioral Care, Inc. CompCare , established in as Comprehensive Care Corporation, became a national leader in chemical dependency treatment services through its trademarked CareUnit programs. In , CompCare began to diversify through acquisition of a small managed behavioral health organization. By , the Company had refocused its core business and consolidated its corporate operations in Tampa, Florida. Today, CompCare manages lives nationwide, providing behavioral health, substance abuse, pharmacy management and employee assistance programs to health plans, governmental agencies, managed care companies, Taft Hartley health and welfare Funds, third party administrators, union sponsored benefit plans, and employer groups throughout the United States. Commercial, Medicaid, and Medicare members.

 

Contact Information

 

 

Current Management

  • Clark A. Marcus / CEO
  • Robert A. Kulbick / President
  • Robert A. Landis / CFO
  • Courtney A. Watson / Secretary

Current Share Structure

  • Market Cap: $7,807,642 - 03/09/2018
  • Authorized: 500,000,000 - 03/09/2018
  • Issue and Outstanding: 65,063,685 - 03/09/2018

 


Recent Filings from (OTC: CHCR)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Amendment to a previously filed Form 3
Filing Type: 3/AFiling Source: edgar
Filing Date: April, 26 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 21 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 14 2016

 

 


Daily Technical Chart for (OTC: CHCR)

Daily Technical Chart for (OTC: CHCR)


Stay tuned for daily updates and more on (OTC: CHCR)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CHCR)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CHCR is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CHCR and does not buy, sell, or trade any shares of CHCR. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/